Overview: Rybelsus 14mg Tablet is an oral GLP-1 receptor agonist used to manage blood glucose levels in adults with type 2 diabetes. It contains Semaglutide, which enhances insulin secretion and lowers glucagon levels, improving glycemic control. Key Benefits: – Oral GLP-1 therapy – Helps in weight reduction – Improves blood sugar control Composition: Semaglutide (14mg) How It Works: Semaglutide mimics the action of the GLP-1 hormone, stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying. Usage Instructions: – Take on an empty stomach with a small amount of water – Wait at least 30 minutes before eating or drinking anything else – Follow the dosage schedule as advised by your physician Side Effects: – Nausea or vomiting – Diarrhea or abdominal discomfort – Headache or dizziness Precautions: – Not for type 1 diabetes or DKA – Monitor kidney function in patients with dehydration – Avoid during pregnancy or breastfeeding without doctor consultation Storage Instructions: – Store below 30°C Manufacturer: Novo Nordisk India Pvt Ltd Disclaimer: This content is for informational purposes only. Please consult your healthcare provider before using any medication.